Can we use old NAFLD data under the new MASLD definition?

doi:10.1016/j.jhep.2023.07.021

Comment

. 2024 Feb;80(2):e54-e56.

doi: 10.1016/j.jhep.2023.07.021. Epub 2023 Aug 2.

Can we use old NAFLD data under the new MASLD definition?

Sherlot Juan Song¹, Jimmy Che-To Lai¹, Grace Lai-Hung Wong¹, Vincent Wai-Sun Wong¹, Terry Cheuk-Fung Yip²

Affiliations

¹ Medical Data Analytics Centre, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China.
² Medical Data Analytics Centre, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China. Electronic address: tcfyip@cuhk.edu.hk.

PMID: 37541393
DOI: 10.1016/j.jhep.2023.07.021

Comment

Can we use old NAFLD data under the new MASLD definition?

Sherlot Juan Song et al. J Hepatol. 2024 Feb.

. 2024 Feb;80(2):e54-e56.

doi: 10.1016/j.jhep.2023.07.021. Epub 2023 Aug 2.

Authors

Sherlot Juan Song¹, Jimmy Che-To Lai¹, Grace Lai-Hung Wong¹, Vincent Wai-Sun Wong¹, Terry Cheuk-Fung Yip²

Affiliations

¹ Medical Data Analytics Centre, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China.
² Medical Data Analytics Centre, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China. Electronic address: tcfyip@cuhk.edu.hk.

PMID: 37541393
DOI: 10.1016/j.jhep.2023.07.021

No abstract available

PubMed Disclaimer

Comment on

A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne CD, Castro Narro GE, Chowdhury A, Cortez-Pinto H, Cryer DR, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot BG, Korenjak M, Kowdley KV, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TR, Powell EE, Roden M, Romero-Gómez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wong VW, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, Newsome PN; NAFLD Nomenclature consensus group. Rinella ME, et al. J Hepatol. 2023 Dec;79(6):1542-1556. doi: 10.1016/j.jhep.2023.06.003. Epub 2023 Jun 24. J Hepatol. 2023. PMID: 37364790 Review.

Cited by

A healthy lifestyle is prospectively associated with lower onset of metabolic dysfunction-associated steatotic liver disease.
Grinshpan LS, Even Haim Y, Ivancovsky-Wajcman D, Fliss-Isakov N, Nov Y, Webb M, Shibolet O, Kariv R, Zelber-Sagi S. Grinshpan LS, et al. Hepatol Commun. 2024 Nov 4;8(11):e0583. doi: 10.1097/HC9.0000000000000583. eCollection 2024 Nov 1. Hepatol Commun. 2024. PMID: 39495134 Free PMC article.
Addressing the looming epidemic of metabolic dysfunction-associated steatotic liver disease in Pakistan: A call for action.
Kamani L, Rahat A, Yilmaz Y. Kamani L, et al. Hepatol Forum. 2024 Jan 16;5(1):1-2. doi: 10.14744/hf.2023.2023.0045. eCollection 2024. Hepatol Forum. 2024. PMID: 38283268 Free PMC article. No abstract available.
Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study.
Nguyen VH, Le I, Ha A, Le RH, Rouillard NA, Fong A, Gudapati S, Park JE, Maeda M, Barnett S, Cheung R, Nguyen MH. Nguyen VH, et al. Clin Mol Hepatol. 2023 Oct;29(4):1002-1012. doi: 10.3350/cmh.2023.0205. Epub 2023 Sep 11. Clin Mol Hepatol. 2023. PMID: 37691484 Free PMC article.
Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk.
Carli F, Sabatini S, Gaggini M, Sironi AM, Bedogni G, Gastaldelli A. Carli F, et al. Int J Mol Sci. 2023 Sep 27;24(19):14651. doi: 10.3390/ijms241914651. Int J Mol Sci. 2023. PMID: 37834099 Free PMC article.
Metabolic Dysfunction-Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options.
Portincasa P, Khalil M, Mahdi L, Perniola V, Idone V, Graziani A, Baffy G, Di Ciaula A. Portincasa P, et al. Int J Mol Sci. 2024 May 22;25(11):5640. doi: 10.3390/ijms25115640. Int J Mol Sci. 2024. PMID: 38891828 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Can we use old NAFLD data under the new MASLD definition?

Affiliations

Can we use old NAFLD data under the new MASLD definition?

Authors

Affiliations

Comment on

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical